Pinna A, di Chiara G, Wardas J, Morelli M
Department of Toxicology, University of Cagliari, viale A. Diaz 182, 09100 Cagliari, Italy.
Eur J Neurosci. 1996 Jun;8(6):1176-81. doi: 10.1111/j.1460-9568.1996.tb01285.x.
In rats with unilateral 6-hydroxydopamine lesions of the dopaminergic nigrostriatal pathway, administration of the A2a adenosine antagonist SCH 58261 alone did not induce any motor asymmetry but strongly potentiated the contralateral turning behaviour induced by the dopamine D1 agonist SKF 38393. SCH 58261 also increased the number of Fos-like positive nuclei induced by SKF 38393 in the 6-hydroxydopamine-lesioned striatum. Intense potentiation of D1-dependent turning behaviour and c-Fos expression was also observed after administration of the A2a/A1 antagonist CGS 15943. Administration of the A1 adenosine receptor antagonist DPCPX induced a small potentiation of D1-mediated contralateral turning while c-Fos expression induced by SKF 38393 was not modified. The results suggest that endogenous adenosine acting on A2a receptors can exert an inhibitory influence on the functional expression of D1-mediated responses in dopamine-denervated rats, and propose new possible therapeutic approaches in the treatment of Parkinson's disease.
在患有多巴胺能黑质纹状体通路单侧6-羟基多巴胺损伤的大鼠中,单独给予A2a腺苷拮抗剂SCH 58261不会诱发任何运动不对称,但会强烈增强多巴胺D1激动剂SKF 38393诱导的对侧旋转行为。SCH 58261还增加了SKF 38393在6-羟基多巴胺损伤纹状体中诱导的Fos样阳性细胞核的数量。在给予A2a/A1拮抗剂CGS 15943后,也观察到对D1依赖性旋转行为和c-Fos表达的强烈增强。给予A1腺苷受体拮抗剂DPCPX会使D1介导的对侧旋转产生轻微增强,而SKF 38393诱导的c-Fos表达未发生改变。结果表明,作用于A2a受体的内源性腺苷可对多巴胺去神经大鼠中D1介导反应的功能表达产生抑制作用,并提出了帕金森病治疗中可能的新治疗方法。